Innoscripta SE Reports Strong Growth in First Half of 2026

Innoscripta SE has announced a successful first half of 2026, reporting a 43% increase in revenue to EUR 63.1 million. Adjusted EBIT rose by 49% year-on-year, reaching EUR 36.4 million. The company's EBIT margin was adjusted to 57.7%.

The German R&D tax allowance continued to be a key growth factor, and customer numbers grew to over 2,900. The firm's platform, Clusterix, improved infrastructure for project handling and bolstered international work efficiency. New market entries in France, the UK, and the US were accomplished, highlighting Innoscripta's strategic expansion.

The management confirms revenue guidance of at least EUR 140 million for the year, with an EBIT target of EUR 80 million. Innoscripta remains focused on leveraging Clusterix's adaptability across diverse markets to drive its international growth.